Traditional and Modern Biomedical Prospecting: Part I—the History

Nature, especially the marine environment, provides the most effective drugs used in human therapy. Among the metazoans, the marine sponges (phylum Porifera), which are sessile filter feeders, produce the most potent and highly selective bioactive secondary metabolites. These animals (or their assoc...

Full description

Bibliographic Details
Main Authors: Werner E. G. Müller, Renato Batel, Heinz C. Schröder, Isabel M. Müller
Format: Article
Language:English
Published: Hindawi Limited 2004-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1093/ecam/neh013
id doaj-7a8f6cc0252c4949ba047dbdb4b0c780
record_format Article
spelling doaj-7a8f6cc0252c4949ba047dbdb4b0c7802020-11-24T23:25:46ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882004-01-0111718210.1093/ecam/neh013Traditional and Modern Biomedical Prospecting: Part I—the HistoryWerner E. G. Müller0Renato Batel1Heinz C. Schröder2Isabel M. Müller3Institut für Physiologische Chemie, Abteilung Angewandte Molekularbiologie, Universität, Duesbergweg 6, D-55099 Mainz, GermanyCenter for Marine Research, Ruder Boskovic Institute, HR-52210 Rovinj, CroatiaInstitut für Physiologische Chemie, Abteilung Angewandte Molekularbiologie, Universität, Duesbergweg 6, D-55099 Mainz, GermanyInstitut für Physiologische Chemie, Abteilung Angewandte Molekularbiologie, Universität, Duesbergweg 6, D-55099 Mainz, GermanyNature, especially the marine environment, provides the most effective drugs used in human therapy. Among the metazoans, the marine sponges (phylum Porifera), which are sessile filter feeders, produce the most potent and highly selective bioactive secondary metabolites. These animals (or their associated symbiotic microorganisms) synthesize secondary metabolites whose activity and selectivity has developed during their long evolutionary history (evochemistry). The exploitation of these resources has become possible due to the progress in molecular and cell biology. BIOTECmarin, the German Center of Excellence follows this rationale. In the past, these animals have been successfully and extensively utilized to isolate bioactive compounds and biomaterials for human benefit. Pharmaceuticals prepared from marine animals, primarily sponges, have been applied since ancient times (Hippocrates, Aristotle and later Plinius). It has been reported that extracts and/or components from sponges can be used for the treatment of specific diseases. For a systematic and applied-oriented exploitation, the successful development of effective compounds largely depends on quality of the institutional infrastructure of marine stations and more so on the biodiversity. The Center for Marine Research in Rovinj (Croatia) fulfils these prerequisites. Founded in 1891, this institute has to its credit major discoveries related to exploitation of secondary metabolites/biomaterials from sponges for therapeutical application and to obtain biomaterials for general wellbeing.This is the first part of a review focusing on biomedical prospecting. Here, we have mainly described the historic background. The details of techniques, substances, approaches and outlooks will be discussed in the second part.http://dx.doi.org/10.1093/ecam/neh013
collection DOAJ
language English
format Article
sources DOAJ
author Werner E. G. Müller
Renato Batel
Heinz C. Schröder
Isabel M. Müller
spellingShingle Werner E. G. Müller
Renato Batel
Heinz C. Schröder
Isabel M. Müller
Traditional and Modern Biomedical Prospecting: Part I—the History
Evidence-Based Complementary and Alternative Medicine
author_facet Werner E. G. Müller
Renato Batel
Heinz C. Schröder
Isabel M. Müller
author_sort Werner E. G. Müller
title Traditional and Modern Biomedical Prospecting: Part I—the History
title_short Traditional and Modern Biomedical Prospecting: Part I—the History
title_full Traditional and Modern Biomedical Prospecting: Part I—the History
title_fullStr Traditional and Modern Biomedical Prospecting: Part I—the History
title_full_unstemmed Traditional and Modern Biomedical Prospecting: Part I—the History
title_sort traditional and modern biomedical prospecting: part i—the history
publisher Hindawi Limited
series Evidence-Based Complementary and Alternative Medicine
issn 1741-427X
1741-4288
publishDate 2004-01-01
description Nature, especially the marine environment, provides the most effective drugs used in human therapy. Among the metazoans, the marine sponges (phylum Porifera), which are sessile filter feeders, produce the most potent and highly selective bioactive secondary metabolites. These animals (or their associated symbiotic microorganisms) synthesize secondary metabolites whose activity and selectivity has developed during their long evolutionary history (evochemistry). The exploitation of these resources has become possible due to the progress in molecular and cell biology. BIOTECmarin, the German Center of Excellence follows this rationale. In the past, these animals have been successfully and extensively utilized to isolate bioactive compounds and biomaterials for human benefit. Pharmaceuticals prepared from marine animals, primarily sponges, have been applied since ancient times (Hippocrates, Aristotle and later Plinius). It has been reported that extracts and/or components from sponges can be used for the treatment of specific diseases. For a systematic and applied-oriented exploitation, the successful development of effective compounds largely depends on quality of the institutional infrastructure of marine stations and more so on the biodiversity. The Center for Marine Research in Rovinj (Croatia) fulfils these prerequisites. Founded in 1891, this institute has to its credit major discoveries related to exploitation of secondary metabolites/biomaterials from sponges for therapeutical application and to obtain biomaterials for general wellbeing.This is the first part of a review focusing on biomedical prospecting. Here, we have mainly described the historic background. The details of techniques, substances, approaches and outlooks will be discussed in the second part.
url http://dx.doi.org/10.1093/ecam/neh013
work_keys_str_mv AT werneregmuller traditionalandmodernbiomedicalprospectingpartithehistory
AT renatobatel traditionalandmodernbiomedicalprospectingpartithehistory
AT heinzcschroder traditionalandmodernbiomedicalprospectingpartithehistory
AT isabelmmuller traditionalandmodernbiomedicalprospectingpartithehistory
_version_ 1725556130626666496